According to the latest report by IMARC Group titled, “Coagulation Analyzer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the market reached a value of US$ 3.6 Billion in 2018. Looking forward, the market is expected to reach a value of US$ 6.2 Billion by 2024, exhibiting a CAGR of around 9.2% during the next five year.
Request for a free sample copy of this report: https://www.imarcgroup.com/coagulation-analyzer-market/requestsample
A coagulation analyzer is a device used in medical laboratories to detect the presence of clots in blood vessels and minimize the probabilities of a heart attack, embolism and thrombosis. It is also used to evaluate the levels of plasma expansion and platelets in the bloodstream. The device operates on the principle of the optical detection method to monitor the changes in the transparency of blood by scattering light through it. Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and Activated Clotting Time (ACT) are the most common types of laboratory tests that utilize coagulation analyzers for examination.
Buy full report with table of contents: https://www.imarcgroup.com/coagulation-analyzer-market
The global market is driven by the growing geriatric population and the increasing prevalence of chronic medical ailments, along with lifestyle-related and hematological disorders. Furthermore, the introduction of technologically advanced and user-friendly variants with increased processing abilities, accuracy and precision, is also providing a boost to the market growth. Other factors, including rising healthcare expenditures of the consumers, an increasing number of healthcare and diagnostic centers, improving automation of laboratories and the introduction of portable analyzers, are projected to drive the market further.
Key Market Segmentation:
Breakup by Testing Type:
1. Prothrombin Time Testing (PT)
2. Fibrinogen Testing
3. Activated Partial Thromboplastin Time Testing (APTT)
4. Activated Clotting Time Testing (ACT)
5. D-Dimer Testing
6. Platelet Function Testing
7. Anti-Factor Xa Testing
Breakup by Product Type:
2. Automated Analyzers
3. Semi-Automated Analyzers
4. Manual Analyzers
Breakup by Technology Type:
1. Optical Technology
2. Mechanical Technology
3. Electrochemical Technology
Market Breakup by End User:
1. Clinical Laboratories
2. Diagnostic Centers
Breakup by Region:
1. North America
3. Asia Pacific
4. Middle East and Africa
5. Latin America
The report has also examined the competitive landscape of global Coagulation Analyzer Market. Some of the major players in the market are Alere Inc., Roche Diagnostics (F. Hoffmann-La Roche Ltd.), Nihon Kohden Corporation, Sysmex Corporation, Siemens Healthcare (AG), Thermo Fisher Scientific Inc., Helena Laboratories, Diagnostica Stago Sas, Instrumentation Laboratory (Werfen Group), International Technidyne Corporation (ITC), etc.
Key highlights of the report:
1. Market Performance
2. Market Outlook
3. Porter’s Five Forces Analysis
4. Market Drivers and Success Factors
5. SWOT Analysis
6. Value Chain
7. Competitive Structure
8. Profiles of Key Players
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
309 2nd St, Brooklyn, NY 11215, USA
Email: [email protected]
USA: +1-631-791-1145, UK: +44-702-409-7331
Follow us on twitter: @imarcglobal
This post was originally published on Market Reports